Preparation and cytotoxicity evaluation of folic acid-modified YF8-OA self-assembled lipid prodrug nanoparticles

References

• Abd-Elsalam WH, El-Zahaby SA, Al-Mahallawi AM. 2018. Formulation and in vivo assessment of terconazole-loaded polymeric mixed micelles enriched with Cremophor EL as dual functioning mediator for augmenting physical stability and skin delivery. Drug Deliv. 25(1):484–492.
   PubMed Web of Science ®Google Scholar
• Ahmed KS, Liu S, Mao J, Zhang J, Qiu L. 2021. Dual-functional peptide driven liposome codelivery system for efficient treatment of doxorubicin-resistant breast cancer. Drug Des Devel Ther. 15:3223–3239.
   PubMed Web of Science ®Google Scholar
• Bildstein L, Dubernet C, Marsaud V, Chacun H, Nicolas V, Gueutin C, Sarasin A, Benech H, Lepetre-Mouelhi S, Desmaele D, et al. 2010. Transmembrane diffusion of gemcitabine by a nanoparticulate squalenoyl prodrug: an original drug delivery pathway. J Control Release. 147(2):163–170.
   PubMed Web of Science ®Google Scholar
• Bradley MO, Swindell CS, Anthony FH, Witman PA, Devanesan P, Webb NL, Baker SD, Wolff AC, Donehower RC. 2001. Tumor targeting by conjugation of DHA to paclitaxel. J Control Release. 74(1-3):233–236.
   PubMed Web of Science ®Google Scholar
• Cao Y, Zhou Y, Zhuang Q, Cui L, Xu X, Xu R, He X. 2015. Anti-tumor effect of RGD modified PTX loaded liposome on prostatic cancer. Int J Clin Exp Med. 8(8):12182–12191.
   PubMed Web of Science ®Google Scholar
• Cheetham AG, Chakroun RW, Ma W, Cui HG. 2017. Self-assembling prodrugs. Chem Soc Rev. 46(21):6638–6663.
   PubMed Web of Science ®Google Scholar
• Cheikh-Ali Z, Caron J, Cojean S, Bories C, Couvreur P, Loiseau PM, Desmaele D, Poupon E, Champy P. 2015. “Squalenoylcurcumin” nanoassemblies as water-dispersible drug candidates with antileishmanial Activity. ChemMedChem. 10(2):411–418.
   PubMed Web of Science ®Google Scholar
• Chu BY, Qu Y, He XL, Hao Y, Yang CL, Yang Y, Hu DR, Wang FF, Qian ZY. 2020. ROS-responsive camptothecin prodrug nanoparticles for on-demand drug release and combination of chemotherapy and photodynamic therapy. Adv Funct Mater. 30(52):2005918.
   Web of Science ®Google Scholar
• Dai JL, Chen M, Xu DM, Li HJ, Qiao YY, Ke X, Ci TY. 2021. Self-assembly delivery system based on small-molecule camptothecin prodrug for treatment of colorectal carcinoma. Nanomedicine. 16(5):355–372.
   PubMed Web of Science ®Google Scholar
• Dong SX, He JL, Sun Y, Li D, Li L, Zhang MZ, Ni PH. 2019. Efficient click synthesis of a protonized and reduction-sensitive amphiphilic small-molecule prodrug containing camptothecin and gemcitabine for a drug self-delivery system. Mol Pharm. 16(9):3770–3779.
   PubMedGoogle Scholar
• Gao C, Bhattarai P, Chen M, Zhang NS, Hameed S, Yue XL, Dai ZF. 2018. Amphiphilic drug conjugates as nanomedicines for combined cancer therapy. Bioconjug Chem. 29(12):3967–3981.
   PubMed Web of Science ®Google Scholar
• Gelderblom H, Verweij J, Nooter K, Sparreboom A. 2001. Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation. Eur J Cancer. 37(13):1590–1598.
   PubMed Web of Science ®Google Scholar
• Irby D, Du CG, Li F. 2017. Lipid-drug conjugate for enhancing drug delivery. Mol Pharm. 14(5):1325–1338.
   PubMed Web of Science ®Google Scholar
• Jiang LH, Wu LC, Yang FF, Almosnid N, Liu X, Jiang J, Altman E, Wang LS, Gao Y. 2017. Synthesis, biological evaluation and mechanism studies of matrine derivatives as anticancer agents. Oncol Lett. 14(3):3057–3064.
   PubMed Web of Science ®Google Scholar
• Lin MH, Hung CF, Hsu CY, Lin ZC, Fang JY. 2019. Prodrugs in combination with nanocarriers as a strategy for promoting antitumoral efficiency. Future Med Chem. 11(16):2131–2150.
   PubMed Web of Science ®Google Scholar
• Ling LB, Ismail M, Shang ZH, Hu YH, Li BH. 2020. Vitamin E-based prodrug self-delivery for nanoformulated irinotecan with synergistic antitumor therapeutics. Int J Pharm. 577:119049.
   PubMedGoogle Scholar
• Liu J, Zhu M, Shi R, Yang M. 2003. Radix Sophorae flavescentis for chronic hepatitis B: a systematic review of randomized trials. Am J Chin Med. 31(3):337–354.
   PubMed Web of Science ®Google Scholar
• Lu L, Li B, Lin CC, Li K, Liu GH, Xia ZZL, Luo Z, Cai KY. 2020. Redox-responsive amphiphilic camptothecin prodrug nanoparticles for targeted liver tumor therapy. J Mater Chem B. 8(17):3918–3928.
   PubMed Web of Science ®Google Scholar
• Lu SJ, Xia R, Wang J, Pei Q, Xie ZG, Jing XB. 2021. Engineering paclitaxel prodrug nanoparticles via redox-activatable linkage and effective carriers for enhanced chemotherapy. ACS Appl Mater Interfaces. 13(39):46291–46302.
   PubMed Web of Science ®Google Scholar
• Ma Y, Mou QB, Zhu XY, Yan DY. 2017. Small molecule nanodrugs for cancer therapy. Mater Today Chem. 4:26–39.
   Web of Science ®Google Scholar
• Owen SC, Chan DPY, Shoichet MS. 2012. Polymeric micelle stability. Nano Today. 7(1):53–65.
   Web of Science ®Google Scholar
• Pei Q, Hu XL, Liu S, Li Y, Xie ZG, Jing XB. 2017. Paclitaxel dimers assembling nanomedicines for treatment of cervix carcinoma. J Control Release. 254:23–33.
   PubMed Web of Science ®Google Scholar
• Rashid HU, Xu Y, Muhammad Y, Wang L, Jiang J. 2019. Research advances on anticancer activities of matrine and its derivatives: an updated overview. Eur J Med Chem. 161:205–238.
   PubMed Web of Science ®Google Scholar
• Saw PE, Yao H, Lin C, Tao W, Farokhzad OC, Xu X. 2019. Stimuli-responsive polymer-prodrug hybrid nanoplatform for multistage siRNA delivery and combination cancer therapy. Nano Lett. 19(9):5967–5974.
   PubMed Web of Science ®Google Scholar
• Shi J, Han G, Wang J, Han X, Zhao M, Duan X, Mi L, Li N, Yin X, Shi H, et al. 2020. Matrine promotes hepatic oval cells differentiation into hepatocytes and alleviates liver injury by suppression of Notch signalling pathway. Life Sci. 261:118354.
   PubMed Web of Science ®Google Scholar
• Shi L, Wang Y, Wang Q, Jiang Z, Ren L, Yan Y, Liu Z, Wan J, Huang L, Cen B, et al. 2020. Transforming a toxic drug into an efficacious nanomedicine using a lipoprodrug strategy for the treatment of patient-derived melanoma xenografts. J Control Release. 324:289–302.
   PubMed Web of Science ®Google Scholar
• Tang H, Murphy CJ, Zhang B, Shen Y, Sui M, Van Kirk EA, Feng X, Murdoch WJ. 2010. Amphiphilic curcumin conjugate-forming nanoparticles as anticancer prodrug and drug carriers: in vitro and in vivo effects. Nanomedicine. 5(6):855–865.
   PubMed Web of Science ®Google Scholar
• Wang Q, Guan JK, Wan JL, Li ZF. 2020. Disulfide based prodrugs for cancer therapy. RSC Adv. 10(41):24397–24409.
   PubMed Web of Science ®Google Scholar
• Wang Y, Xie H, Ying K, Xie B, Chen X, Yang B, Jin J, Wan J, Li T, Han W, et al. 2021. Tuning the efficacy of esterase-activatable prodrug nanoparticles for the treatment of colorectal malignancies. Biomaterials. 270:120705.
   PubMed Web of Science ®Google Scholar
• Wolff AC, Donehower RC, Carducci MK, Carducci MA, Brahmer JR, Zabelina Y, Bradley MO, Anthony FH, Swindell CS, Witman PA, et al. 2003. Phase I study of docosahexaenoic acid-paclitaxel: a taxane-fatty acid conjugate with a unique pharmacology and toxicity profile. Clin Cancer Res. 9(10 Pt 1):3589–3597.
   PubMed Web of Science ®Google Scholar
• Yang Y, Sun B, Zuo S, Li X, Zhou S, Li L, Luo C, Liu H, Cheng M, Wang Y, et al. 2020. Trisulfide bond-mediated doxorubicin dimeric prodrug nanoassemblies with high drug loading, high self-assembly stability, and high tumor selectivity. Sci Adv. 6(45):eabc1725.
   Web of Science ®Google Scholar
• Zarrintaj P, Ramsey JD, Samadi A, Atoufi Z, Yazdi MK, Ganjali MR, Amirabad LM, Zangene E, Farokhi M, Formela K, et al. 2020. Poloxamer: a versatile tri-block copolymer for biomedical applications. Acta Biomater. 110:37–67.
   PubMed Web of Science ®Google Scholar
• Zeng J, Li C, Duan X, Liu F, Li A, Luo C, Jia L, Gan Y, Yan L, Zheng Y. 2019. PEGylation of lipophilic SN38 prodrug with DSPE-PEG2000 versus Cremophor EL: comparative study for intravenous chemotherapy. Drug Deliv. 26(1):354–362.
   PubMed Web of Science ®Google Scholar
• Zhang H, Chen L, Sun X, Yang Q, Wan L, Guo C. 2020. Matrine: a promising natural product with various pharmacological activities. Front Pharmocol. 11:588.
   PubMed Web of Science ®Google Scholar
• Zhang H, Wang J, Mao W, Huang J, Wu X, Shen Y, Sui M. 2013. Novel SN38 conjugate-forming nanoparticles as anticancer prodrug: in vitro and in vivo studies. J Control Release. 166(2):147–158.
   PubMed Web of Science ®Google Scholar
• Zhang J, Xiang L, Yan B, Zeng H. 2020. Nanomechanics of anion-pi interaction in aqueous solution. J Am Chem Soc. 142(4):1710–1714.
   PubMed Web of Science ®Google Scholar
• Zhang JP, Zhang M, Zhou JP, Liu FT, Zhou B, Xie WF, Guo C, Zhang C, Qian DH. 2001. Antifibrotic effects of matrine on in vitro and in vivo models of liver fibrosis in rats. Acta Pharmacol Sin. 22(2):183–186.
   PubMed Web of Science ®Google Scholar
• Zheng O, Zhao J-X. 2006. Solubilization of pyrene in aqueous micellar solutions of gemini surfactants C12-s-C12⋅2Br. J Colloid Interface Sci. 300(2):749–754.
   PubMed Web of Science ®Google Scholar